Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Alkermes plc | 12 | 2 | 3 | 1 | €22.20 | €34.08 | 53.517% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €6.05 | €15.50 | 156.114% |
| Chromadex Corp | 10 | 2 | 1 | 1 | €3.58 | €5.76 | 60.793% |
| Maternus-Kliniken AG | 1 | 0 | 0 | 0 | €1.93 | - | - |
| Evolus Inc | 7 | 0 | 2 | 0 | €10.90 | €20.11 | 84.477% |
| UnitedHealth Group Inc. | 33 | 1 | 7 | 0 | €463.45 | €543.72 | 17.320% |
| Immunic Inc. | 7 | 1 | 2 | 1 | €1.18 | €4.53 | 282.644% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.48 | €3.00 | 525.652% |
| Baxter International | 3 | 0 | 0 | 0 | €37.25 | €48.16 | 29.291% |
| Valneva SE | 2 | 0 | 0 | 0 | €3.66 | €7.00 | 91.361% |
| Exact Sciences | 11 | 0 | 1 | 0 | €59.64 | €83.49 | 39.998% |
| Dexcom Inc. | 17 | 0 | 2 | 0 | €126.16 | €136.81 | 8.442% |
| Dentsply Sirona Inc. | 10 | 0 | 0 | 0 | €28.59 | €38.55 | 34.844% |
| Krystal Biotech | 15 | 0 | 2 | 0 | €154.00 | €166.84 | 8.339% |
| Medpace Holdings Inc | 6 | 0 | 0 | 0 | €351.60 | €399.91 | 13.739% |
| Stoke Therapeutics Inc | 15 | 1 | 7 | 1 | €11.00 | €21.39 | 94.482% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 1 | €11.01 | €22.78 | 106.954% |
| Personalis Inc | 5 | 0 | 1 | 0 | €1.15 | €3.23 | 180.521% |
| XOMA Corp. | 3 | 0 | 0 | 0 | €23.00 | €68.62 | 198.349% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €210.00 | - | - |
| Ensign Group Inc. | 7 | 0 | 0 | 0 | €110.00 | €116.00 | 5.455% |
| Merit Medical Systems | 13 | 0 | 2 | 0 | €66.00 | €86.72 | 31.389% |
| United Therapeutics | 15 | 0 | 0 | 0 | €222.50 | €289.92 | 30.301% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Innoviva Inc. | 4 | 0 | 2 | 0 | €13.80 | €25.25 | 82.954% |